The rationale for including immune checkpoint inhibition into multimodal primary treatment concepts of head and neck cancer

BACKGROUND: Treatment of locally advanced squamous cell carcinomas of the head and neck (SCCHN) remains unsatisfactory. Although the addition of concurrent radiochemotherapy (RCT) or the combination of radiotherapy with blockade of the epidermal growth factor receptor (EGFR) have improved outcomes o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tinhofer, Ingeborg, Budach, Volker, Jöhrens, Korinna, Keilholz, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460729/
https://www.ncbi.nlm.nih.gov/pubmed/31093338
http://dx.doi.org/10.1186/s41199-016-0009-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460729/
https://www.ncbi.nlm.nih.gov/pubmed/31093338
http://dx.doi.org/10.1186/s41199-016-0009-6

Ejemplares similares